I, too, thank Emma Harper for lodging this important motion, and I welcome the opportunity to respond to the debate on behalf of the Scottish Government.
I put on record my thanks to those who support people living with asthma in Scotland, including NHS staff and third sector organisations such as Asthma and Lung UK. I also recognise, as a polite agitator of the group, the important work of the cross-party group on lung health, which is chaired by co-conveners Emma Harper and Alexander Stewart. I am always pleased to attend those meetings.
The debate has been valuable, and I thank everyone who has contributed for recognising that, across all parties, we share the desire to raise awareness of asthma and ensure that the people who live with it receive the best possible care.
Last night, I was pleased to join a round-table event on interstitial lung disease, which was hosted by Colin Smyth. One of the attendees at that session reminded me, and everyone in the room, of the importance of listening to those who are living with respiratory conditions when we are shaping policy; members have commented on that in the debate.
Although asthma is not directly a cardiovascular disease, it can increase the risk of developing such diseases. Yesterday, I had a conversation with the chief medical officer, who had hosted a webinar for about 1,000 GPs on respiratory disease. A lot of work is constantly going on in the background.
I will touch on a couple of points that have been raised by Emma Harper, Maurice Golden and others. They are right—the statistics on asthma deaths are alarming; that was the preamble to my conversation with the chief medical officer yesterday. The Scottish Government is absolutely committed to preventing avoidable harm, and I thank members for continuing to highlight the risks.
We know that most people with asthma are treated by their GP or practice nurse, and we have committed a greater proportion of new NHS funding to primary and community care so that GPs and services in the community will have the resources that they need for their essential role in managing conditions such as asthma.
Maurice Golden and Carol Mochan both highlighted the Government’s respiratory care action plan. We continue to support a number of projects via NHS partners, and the action plan is still being supported. However, as I am sure that members from all parties are aware, we are consulting on a long-term conditions framework. The consultation runs until 20 July. As I said at the event last night, I see that framework as being very similar to our cancer framework, in which there are common areas across different cancers that are joined up and specific strands of work for outcomes on specific cancers. I encourage everybody who is living with asthma to respond to the consultation so that the perspectives of people with respiratory conditions are properly reflected in the consultation.
Carol Mochan correctly raised a point about the importance of data. In 2023, as she will know, the Scottish Government provided Public Health Scotland with funding to undertake a scoping exercise to develop a respiratory audit programme. I absolutely recognise the importance of having that meaningful data, and we are considering what the best way forward is with that work.
World asthma day allows us time to reflect on the progress that has been made in respiratory care, and on the challenges that we face. We know that care and treatment for asthma are not always where they need to be; that is reflected in the concerning statistics on asthma deaths last year, as many members have mentioned. The Scottish Government is committed to improving services across the country in order to meet people’s needs through the implementation of the respiratory care action plan.
The theme of this year’s world asthma day, as many members have said, is “Make Inhaled Treatments Accessible for ALL”. We know that around 360,000 people in Scotland have a diagnosis of asthma and that it is the most common respiratory condition impacting people of all ages. Most people living with asthma are supported well by their GP and practice nurse. However, we recognise that there is a way to go to ensure that everyone gets the care that they need at all stages of their life. That, too, was highlighted in the discussion at the round-table event last night. We were also reminded by Emily Kennedy, of the Royal Pharmaceutical Society, of the support that community pharmacies can also provide.
Over the past year, a major milestone in asthma care has been the publication of a new guideline on asthma diagnosis, monitoring and management, as Emma Harper laid out. That guidance was a collaboration between the British Thoracic Society, NICE and SIGN, and signals a shift in asthma care. It aims to improve the accuracy of diagnosis and to help people to control their asthma and reduce their risk of asthma attacks.
We know that diagnosis of asthma is a key area for improvement, and the guideline recommends a change in investigations to simplify the diagnostic pathway. As Alexander Stewart mentioned, changes include using FeNO breath tests and blood investigations alongside traditional tests, such as spirometry and peak-flow measurements. We hope that that directs us towards standardised, evidence-based care that will improve outcomes for everyone living with asthma. We will now work with key stakeholders across health and social care to ensure that those guidelines become a reality for clinical professions and those who live with asthma.
A key part of that will be continuing to promote the quality prescribing guide for improvement in respiratory conditions, which was published last year. The guide aims to keep people at the centre of their treatment and promotes safe and sustainable evidence-based prescribing. It highlights the importance of people with asthma having access to personalised asthma action plans. As Emma Harper mentioned, the guide also highlights that each person should receive training on how to use their inhalers properly.
We understand that, for those who are living with asthma and other conditions, environmental factors play a huge role in their daily lives, as Clare Adamson laid out so well when she referenced the sad death of Ella in London. Our vision is for Scotland to have the cleanest air in Europe, and we are committed to protecting people from the effects and harms of poor air quality. For example, the introduction of low-emission zones in our four largest cities from 2022 was a key initiative to further improve urban air quality. I note a number of members’ points about air pollution monitors in other locations, and I will speak to Government colleagues with regard to that.
As Gillian Mackay noted, Scotland also has in place a range of world-leading tobacco control measures. We are committed to creating a tobacco-free Scotland by 2034, and we welcome the reintroduction of the UK-wide Tobacco and Vapes Bill, which will help us to achieve our ambitious target as smoking rates continue to decline. That suite of prevention measures will help people to better manage their condition and support us in our work to prevent respiratory disease in future generations.
I close by reiterating our commitment to ensuring that everyone who is living with asthma in Scotland receives the best possible treatment, care and support. We know that there is still more to do in respiratory care, and we can improve by better understanding the needs of people who are living with asthma, as I was so eloquently reminded at the round-table event last night.